Thanks to the success of its COVID-19 vaccine, the drug giant Pfizer has become a household name around the globe—and the company’s eyeing $ 15 billion in sales from the shot this year. For writing that 2020 success story, CEO Albert Bourla collected a pay package worth more than $ 21 million. Bourla, who took… Read More »
While the number of people infected with Covid-19 remains high it’s more likely that new variants will appear, so vaccine developers are having to deal with the rapidlyevolving virus and are looking for ‘second generation’ vaccines. Danny Altmann, professor of immunology at Imperial College London, says it may be wise to “hedge your bets”. “What… Read More »
Breadcrumb Trail Links News Health Canada The legal action targets tweets that began after Gill wrote that society has existing COVID defences in the form of ‘the Truth … T-cell immunity … Hydroxychloroquine’ Author of the article: Tom Blackwell Publishing date: Mar 04, 2021 • 2 days ago • 5 minute read • 1091 Comments Doctors… Read More »
[unable to retrieve full-text content]A single dose of the Pfizer or Oxford vaccine cuts hospital admissions of older people by about 80%. BBC News – Health
The Food and Drug Administration on Saturday gave emergency authorization to a coronavirus vaccine developed by Johnson & Johnson, making a third shot available at a critical moment for U.S. efforts to control COVID-19. J&J’s vaccine, which requires one dose rather than two and can be stored at refrigerator temperatures, will provide much-needed reinforcements as… Read More »
The Italian government says that the uneven distribution of vaccines between developed and developing countries is a key concern of Group of 20 nations as leaders consider how to create an even recovery from the pandemic By COLLEEN BARRY Associated Press February 26, 2021, 5:56 PM • 2 min read MILAN — The uneven distribution… Read More »